Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

It’s Time to Get Bullish on Electronic Arts Inc. Stock

By Luke Lango, InvestorPlace Senior Investment Analyst Jan 29, 2018

It looks like Electronic Arts had a strong holiday quarter thanks to a surge in video game sales. If so, EA stock could head much higher in the near term.

How to Make Money on Investor Indecision Over AMD Stock

By James Brumley, InvestorPlace Feature Writer Jan 29, 2018

Advanced Micro Devices, Inc. is at a fork in the road as earnings news approaches. This is a case where you can, and should, play both sides of AMD stock with options.

Don’t Laugh, But It’s Time to Buy Nokia Stock

By Will Healy, InvestorPlace Contributor Jan 29, 2018

Nokia is redefining itself as an equipment provider and becoming vital in 5G. With Nokia stock trading below $5, now is the time for investors to buy in and profit on NOK's comeback.

Why JD.Com Inc (ADR) Stock Has More Upside Than Amazon

By Will Ashworth, InvestorPlace Contributor Jan 29, 2018

Understanding history is important for so many reasons. If investors evaluate the history of JD.com and Amazon, they'll see that JD stock has more upside.

AT&T Inc. Stock Will Leap MUCH Higher in 2018

By Luke Lango, InvestorPlace Senior Investment Analyst Jan 29, 2018

T stock has had a rough start to 2018, but that could all change on Wednesday, when the company reports what could be a blowout quarter.

Upcoming CVS Deal Will Reward Aetna Inc Shareholders

By James Brumley, InvestorPlace Feature Writer Jan 29, 2018

AET stock isn't a buy here, but only for logistical reasons. If you're already an Aetna shareholder, just hang on because it's about to get even better.

Why Volkswagen AG (ADR) Stock Can Make a Comeback

By Lawrence Meyers, InvestorPlace Contributor Jan 29, 2018

Volkswagen's lousy PR is on the mend, and so is VKLAY stock. Here's what investors should know about the comeback in VKLAY stock.

Alibaba Group Holding Ltd Earnings: Get Ready for a Blowout

By Tom Taulli, InvestorPlace Contributor Jan 29, 2018

Next week, Alibaba will report its fourth quarter results. And yes, expect a strong performance. The company’s ecommerce business is likely to see strong growth from the holiday. But there should also be notable strength from the cloud computing and entertainment segments.

You Definitely Should Buy Celgene Corporation Stock After Earnings Beat

By Bret Kenwell, InvestorPlace Contributor Jan 29, 2018

Celgene shares have traded mixed since reporting earnings. However, management told a reassuring story and CELG stock is one to buy at these levels.

3 Things Driving AbbVie Inc. Stock After Q4 Earnings Report

By Chris Fraley, InvestorPlace Contributor Jan 29, 2018

AbbVie Inc. (NYSE:ABBV) reported fourth-quarter and full-year earnings Friday morning, and AbbVie stock responded by jumping more than 10% in early trading. What did the pharmaceuticals giant do right? There are three things that stood out.

Don’t Chase AbbVie Inc Stock After Its Huge Earnings Win

By Vince Martin, InvestorPlace Contributor Jan 26, 2018

AbbVie's Q4 beat shows a company operating on all cylinders. But the nature of the drug space shows that's precisely when long-term investors need to be most cautious.

5 Biotech and Pharmaceutical Stocks Going Bonkers

By Anthony Mirhaydari, InvestorPlace Market Strategist Jan 26, 2018

These biotech and pharmaceutical stocks are soaring insanely high right now. Here's what investors should know about each of these hot stocks to buy.

How Much Higher Can Intel Corporation Stock Go?

By Luke Lango, InvestorPlace Senior Investment Analyst Jan 26, 2018

Intel has bounced back from a security-related selloff in early January, and strong quarterly numbers imply that INTC stock has more room to run.

Pfizer Inc. Stock Rises From the Dead, Deserves to Be in Your Portfolio

By Lawrence Meyers, InvestorPlace Contributor Jan 26, 2018

PFE stock is back on track, and Pfizer Inc. may be too. With increasing revenues and several new drugs in the pipeline, PFE looks like a stock to add to your portfolio.